BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32651736)

  • 1. Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis.
    Zhao K; Li R; Wu X; Zhao Y; Wang T; Zheng Z; Zeng S; Ding X; Nie H
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2279-2287. PubMed ID: 32651736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China.
    Li J; Gong X; Wang Z; Chen R; Li T; Zeng D; Li M
    Virus Res; 2020 Sep; 286():198043. PubMed ID: 32502551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood routine test in mild and common 2019 coronavirus (COVID-19) patients.
    Djakpo DK; Wang Z; Zhang R; Chen X; Chen P; Antoine MMLK
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
    Yang X; Yu Y; Xu J; Shu H; Xia J; Liu H; Wu Y; Zhang L; Yu Z; Fang M; Yu T; Wang Y; Pan S; Zou X; Yuan S; Shang Y
    Lancet Respir Med; 2020 May; 8(5):475-481. PubMed ID: 32105632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory abnormalities and risk factors associated with in-hospital death in patients with severe COVID-19.
    Chen X; Yan L; Fei Y; Zhang C
    J Clin Lab Anal; 2020 Oct; 34(10):e23467. PubMed ID: 32656888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
    Zhao Y; Nie HX; Hu K; Wu XJ; Zhang YT; Wang MM; Wang T; Zheng ZS; Li XC; Zeng SL
    Infect Dis Poverty; 2020 Aug; 9(1):108. PubMed ID: 32746940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the clinical profile, laboratory parameters and outcome of two hundred COVID-19 patients from a tertiary centre in India.
    Gupta N; Ish P; Kumar R; Dev N; Yadav SR; Malhotra N; Agrawal S; Gaind R; Sachdeva H; Covid Working Group OMOTSH
    Monaldi Arch Chest Dis; 2020 Nov; 90(4):. PubMed ID: 33169598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of serum amyloid A in patients with COVID-19.
    Cheng L; Yang JZ; Bai WH; Li ZY; Sun LF; Yan JJ; Zhou CL; Tang BP
    Infection; 2020 Oct; 48(5):715-722. PubMed ID: 32734556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: A comparative study.
    Soliman AT; Prabhakaran Nair A; Al Masalamani MS; De Sanctis V; Abu Khattab MA; Alsaud AE; Sasi S; Ali EA; Ola A H; Iqbal FM; Nashwan AJ; Fahad J; El Madhoun I; Yassin MA
    Acta Biomed; 2020 Sep; 91(3):e2020010. PubMed ID: 32921708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy.
    Ciceri F; Castagna A; Rovere-Querini P; De Cobelli F; Ruggeri A; Galli L; Conte C; De Lorenzo R; Poli A; Ambrosio A; Signorelli C; Bossi E; Fazio M; Tresoldi C; Colombo S; Monti G; Fominskiy E; Franchini S; Spessot M; Martinenghi C; Carlucci M; Beretta L; Scandroglio AM; Clementi M; Locatelli M; Tresoldi M; Scarpellini P; Martino G; Bosi E; Dagna L; Lazzarin A; Landoni G; Zangrillo A
    Clin Immunol; 2020 Aug; 217():108509. PubMed ID: 32535188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-19.
    Sun L; Song F; Shi N; Liu F; Li S; Li P; Zhang W; Jiang X; Zhang Y; Sun L; Chen X; Shi Y
    J Clin Virol; 2020 Jul; 128():104431. PubMed ID: 32442756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and potential risk factors for discerning the critical cases and predicting the outcome of patients with COVID-19.
    Wang W; Zhao Z; Liu X; Liu G; Xie D; Xu Z; Zhao J; Zhang J
    J Clin Lab Anal; 2020 Oct; 34(10):e23547. PubMed ID: 32860454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
    Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
    Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
    Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
    Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.
    Gao Y; Li T; Han M; Li X; Wu D; Xu Y; Zhu Y; Liu Y; Wang X; Wang L
    J Med Virol; 2020 Jul; 92(7):791-796. PubMed ID: 32181911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of fatality including radiographic findings in adults with COVID-19.
    Li K; Chen D; Chen S; Feng Y; Chang C; Wang Z; Wang N; Zhen G
    Respir Res; 2020 Jun; 21(1):146. PubMed ID: 32527255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis.
    Yamada T; Wakabayashi M; Yamaji T; Chopra N; Mikami T; Miyashita H; Miyashita S
    Clin Chim Acta; 2020 Oct; 509():235-243. PubMed ID: 32533986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.